Rheumatoid Arthritis Drugs/Therapeutics Market Analysis By Drugs (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic Agents, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By End-Users (Hospitals, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), and By Region: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2024-2032

Global Rheumatoid Arthritis Drugs/Therapeutics market size earned $18.55 Bn in 2023 and is expected to hit $30.15 Bn by 2032, with a projected CAGR of 5.50%.

全球类风湿性关节炎药物/治疗市场在2023年实现了185.5亿美元的规模，预计到2032年将达到301.5亿美元，预测年复合增长率（CAGR）为5.50%。